Patient Guide: Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 108 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT02938520
Status: ACTIVE_NOT_RECRUITING
Condition: HIV Infections
Phase: PHASE3

Find a Study Location Near You

This study is available at 108 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Bakersfield, California
  • Long Beach, California
  • • And 105 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily